Kết quả tìm kiếm - Hirak Der‐Torossian
- Đang hiển thị 1 - 12 kết quả của 12
-
1
-
2
Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics Bằng Michael J. Toth, Mark S. Miller, Damien M. Callahan, Andrew P. Sweeny, Ivette A. Nuñez, Steven M. Grunberg, Hirak Der‐Torossian, Marion E. Couch, Kim Dittus
Được phát hành 2013Artigo -
3
Adagrasib in Advanced Solid Tumors Harboring a <i>KRAS</i><sup><i>G12C</i></sup> Mutation Bằng Tanios Bekaii‐Saab, Rona Yaeger, Alexander I. Spira, Meredith Pelster, Joshua K. Sabari, Navid Hafez, Minal Barve, Karen Velastegui, Xiaohong Yan, Aditya Shetty, Hirak Der‐Torossian, Shubham Pant
Được phát hành 2023Artigo -
4
LBA6 KRYSTAL-1: Adagrasib (MRTX849) as monotherapy or combined with cetuximab (Cetux) in patients (Pts) with colorectal cancer (CRC) harboring a KRASG12C mutation Bằng J. Weiß, Rona Yaeger, Melissa L. Johnson, Alexander I. Spira, Samuel J. Klempner, Minal Barve, James G. Christensen, Andrew Chi, Hirak Der‐Torossian, Karen Velastegui, Thian Kheoh, S-H.I. Ou
Được phát hành 2021Artigo -
5
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With <i>KRAS<sup>G12C</sup></i>-Mutated Non–Small-Cell Lung Cancer Who Have Untreated CNS Metastases Bằng Marcelo V. Negrão, Alexander I. Spira, Rebecca S. Heist, Pasi A. Jänne, Jose M. Pacheco, Jared Weiss, Shirish M. Gadgeel, Karen Velastegui, Wenjing Yang, Hirak Der‐Torossian, James G. Christensen, Joshua K. Sabari
Được phát hành 2023Artigo -
6
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated <i>KRAS</i> G12C Bằng Rona Yaeger, Jared Weiss, Meredith Pelster, Alexander I. Spira, Minal Barve, Sai‐Hong Ignatius Ou, Ticiana Leal, Tanios Bekaii‐Saab, Cloud P. Paweletz, Grace A. Heavey, James G. Christensen, Karen Velastegui, Thian Kheoh, Hirak Der‐Torossian, Samuel J. Klempner
Được phát hành 2022Artigo -
7
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i>G12C-Mutated Metastatic Colorectal Cancer Bằng Rona Yaeger, Nataliya V. Uboha, Meredith S. Pelster, Tanios Bekaii‐Saab, Minal Barve, Joel Saltzman, Joshua K. Sabari, Julio A. Peguero, Andrew Scott Paulson, Pasi A. Jänne, Marcia Cruz‐Correa, Kenna Anderes, Karen Velastegui, Xiaohong Yan, Hirak Der‐Torossian, Samuel J. Klempner, Scott Kopetz
Được phát hành 2024Artigo -
8
Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation Bằng Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel, Rebecca S. Heist, Sai‐Hong Ignatius Ou, Jose M. Pacheco, Melissa L. Johnson, Joshua K. Sabari, Konstantinos Leventakos, Edwin Yau, Lyudmila Bazhenova, Marcelo V. Negrão, Nathan A. Pennell, Jun Zhang, Kenna Anderes, Hirak Der‐Torossian, Thian Kheoh, Karen Velastegui, Xiaohong Yan, James G. Christensen, Richard C. Chao, Alexander I. Spira
Được phát hành 2022Artigo -
9
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma Bằng José A. Karam, Pavlos Msaouel, Cara Haymaker, Surena F. Matin, Matthew T. Campbell, Amado J. Zurita, Amishi Y. Shah, Ignacio I. Wistuba, Enrica Marmonti, Dzifa Y. Duose, Edwin R. Parra, Luisa M. Solis Soto, Caddie Laberiano-Fernández, Marisa Lozano, Alice Abraham, Max Hallin, Curtis D. Chin, Peter Olson, Hirak Der‐Torossian, Xiaohong Yan, Nizar M. Tannir, Christopher G. Wood
Được phát hành 2023Artigo -
10
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial Bằng Pavlos Msaouel, Kai Yu, Ying Yuan, Jianfeng Chen, Xinmiao Yan, Menuka Karki, Fei Duan, Rahul A. Sheth, Priya Rao, Kanishka Sircar, Amishi Y. Shah, Amado J. Zurita, Giannicola Genovese, Yi Liu, Chih‐Chen Yeh, Minghao Dang, Guangchun Han, Yanshuo Chu, Max Hallin, Peter Olson, Rui Yang, Daniela A Slavin, Hirak Der‐Torossian, Curtis D. Chin, Nizar M. Tannir, Linghua Wang, Jianjun Gao
Được phát hành 2025Artigo -
11
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study Bằng Marc Oliva, Douglas B. Chepeha, Daniel Vilarim Araújo, J. Javier Díaz-Mejía, Peter Olson, Amy Prawira, Anna Spreafico, Scott V. Bratman, Tina Shek, John R. de Almeida, Aaron R. Hansen, Andrew Hope, David P. Goldstein, Ilan Weinreb, Stephen Smith, Bayardo Perez‐Ordoñez, Jonathan Irish, Dax Torti, Jeffrey P. Bruce, Ben X. Wang, Anthony J. Fortuna, Trevor J. Pugh, Hirak Der‐Torossian, Ronald Shazer, Nickolas Attanasio, Qingyan Au, Antony Tin, Jordan Feeney, Himanshu Sethi, Alexey Aleshin, Isan Chen, Lillian L. Siu
Được phát hành 2021Artigo -
12
Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer Bằng Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco, Esther Kaplun, Yijun Gao, HuiYong Zhao, Arnaud Da Cruz Paula, Yingjie Zhu, Almudena Chaves Perez, Kalyani Chadalavada, Edison Tse, Sudhir Chowdhry, Sydney Bowker, Qing Chang, Besnik Qeriqi, Britta Weigelt, Gouri J. Nanjangud, Michael F. Berger, Hirak Der‐Torossian, Kenna Anderes, Nicholas D. Socci, Jinru Shia, Gregory J. Riely, Yonina R. Murciano‐Goroff, Bob T. Li, James G. Christensen, Jorge S. Reis‐Filho, David B. Solit, Elisa de Stanchina, Scott W. Lowe, Neal Rosen, Sandra Misale
Được phát hành 2022Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Internal medicine
Medicine
Cancer
Oncology
Colorectal cancer
Adverse effect
Clinical endpoint
Clinical trial
Gastroenterology
KRAS
Biology
Cancer research
Cetuximab
Immunotherapy
Nivolumab
Phases of clinical research
Clear cell renal cell carcinoma
Cohort
Confidence interval
Endocrinology
Lung cancer
Pathology
Renal cell carcinoma
Actin
Biochemistry
Breast cancer
Cachexia
Cancer cachexia
Cancer therapy
Carcinoma